Antibody-Drug Conjugates and Immunotoxins : From Pre-Clinical Development to Therapeutic Applications / / edited by Gail Lewis Phillips
| Antibody-Drug Conjugates and Immunotoxins : From Pre-Clinical Development to Therapeutic Applications / / edited by Gail Lewis Phillips |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | New York, NY : , : Springer New York : , : Imprint : Humana, , 2013 |
| Descrizione fisica | 1 online resource (369 p.) |
| Disciplina |
615.37
615.373 |
| Altri autori (Persone) | PhillipsGail Lewis |
| Collana | Cancer Drug Discovery and Development |
| Soggetto topico |
Cancer
Medicine - Research Biology - Research Immunospecificity Cancer Biology Biomedical Research Adaptive Immunity |
| ISBN |
1-283-93413-2
1-4614-5456-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Antibody Directed Delivery for Treatment of Cancer: Antibody Drug Conjugates and Immunotoxins -- Antibody-Drug Conjugate Development -- Components of ADC Development: Assay Methodologies and Challenges -- Clinical Pharmacology Strategies in the Development of Antibody-Drug Conjugates -- Predictive Biomarkers for Antibody-Drug Conjugates -- Factors Involved in the Design of Cytotoxic Payloads for Antibody-Drug Conjugates -- Linker Technology and Impact of Linker Design on ADC Properties -- Antibody-drug conjugates for the treatment of B-cell malignancies -- Targeting CD19 with SAR3419, an anti-CD19-Maytansinoid Conjugate for the Treatment of B Cell Malignancies -- Brentuximab Vedotin (SGN-35) for CD30 Positive Malignancies -- Trastuzumab Emtansine (T-DM1) for the Treatment of HER2-Positive Cancer -- CDX-011 (Glembatumumab Vedotin, CR011-vcMMAE) -- Case Study: An Antibody-Drug Conjugate Targeting MUC16 for Ovarian Cancer -- EphA2 Immunoconjugate -- Anti-PSMA Antibody-Drug Conjugates -- Targeting CD56 (NCAM)-expressing Neoplasms with Lorvotuzumab Mertansine -- Studies on the Metabolism of Antibody-Drug Conjugates -- Design, Development and Characterization of Recombinant Immunotoxins Targeting HER2/neu -- The Preclinical and Clinical Evaluation of VB6-845: An Immunotoxin with a De-Immunized Payload for the Systemic Treatment of Solid Tumors -- Index. |
| Record Nr. | UNINA-9910437996003321 |
| New York, NY : , : Springer New York : , : Imprint : Humana, , 2013 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antibody-mediated drug delivery systems [[electronic resource] ] : concepts, technology, and applications / / edited by Yashwant Pathak, Simon Benita
| Antibody-mediated drug delivery systems [[electronic resource] ] : concepts, technology, and applications / / edited by Yashwant Pathak, Simon Benita |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2012 |
| Descrizione fisica | 1 online resource (542 p.) |
| Disciplina | 615.37 |
| Altri autori (Persone) |
PathakYashwant
BenitaSimon <1947-> |
| Soggetto topico |
Antibody-drug conjugates
Drug delivery systems |
| ISBN |
1-280-58983-3
9786613619662 1-118-22889-8 1-118-22901-0 1-118-22884-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Antibody mediated drug delivery systems : a general review and applications / Navdeep Kaur, Karthikeyan Subramani, and Y.V. Pathak -- Immunoliposomes for cardiovascular targeting / Tatyana Levchenko, William Hartner, and Vladimir P. Torchilin -- Antibody mediated drug delivery systems for breast cancer therapeutics / Leonor Munoz Alcivar and Y.V. Pathak -- Development of immunonconjugates for in vivo delivery : cancer diagnosis, imaging, and therapy / Arut Selvan -- Mathematical models of anti-TNF therapies and their correlation with tuberculosis / Simeone Marino ... [et al.] -- Targeted nanoparticles in radiotherapy / Misty Muscarella and Y.V. Pathak -- Electrically-enhanced delivery of drugs and conjugates for cancer treatment / Arut Selvan, Luca Campana, and Raji Sundararajan -- Characterization of mAb variants and glycosylation / Ting Zheng ... [et al.] -- Antibody mediated drug delivery system for lymphatic targeting treatment / Fang Wu, Hong Ding, and Zhirong Zhang -- Methods for nanoparticle conjugation to monoclonal antibodies (mAbs) / Junling Li and Chin K. Ng -- Single use systems in animal cell-based bioproduction / William G. Whitford -- Immunoliposomes for specific drug delivery / Manuela Calin -- Gene therapy targeting kidney diseases : routes & vehicles / Yoshitaka Isaka, Yoshitsugu Takabatake, and Hiromi Rakugi -- Detection of antibodies to polyethylene glycol polymers using a double antigen bridging immunogenicity ELISA / Yijuan Liu ... [et al.] -- Antibodies in nanomedicine and microimaging methods / Rakesh Sharma -- Methods for polymeric nanoparticle conjugation to mAb / Uyen Minh Le, Hieu Tran, and Y.V. Pathak -- Plant-derived antibodies for academic, industrial, and therapeutic application / Slavko Komarnytsk and Nikolai Borisjuk -- Monoclonal antibodies as biopharmaceuticals / Girish J. Kotwal -- Pulmonary targeting of nanoparticles and monoclonal antibodies (mAb) / Weiyuan Chang -- Antibody mediated arthritis and new therapeutic avenues / Kutty Selva Nandakumar -- Immuno-nanoparticles for nuclear imaging and radiotherapy / Oren Giladi and Simon Benita -- Monoclonal antibodies in the treatment of asthma / Glenn J. Whelan. |
| Record Nr. | UNINA-9910141297903321 |
| Hoboken, N.J., : Wiley, c2012 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antibody-mediated drug delivery systems : concepts, technology, and applications / / edited by Yashwant Pathak, Simon Benita
| Antibody-mediated drug delivery systems : concepts, technology, and applications / / edited by Yashwant Pathak, Simon Benita |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2012 |
| Descrizione fisica | 1 online resource (542 p.) |
| Disciplina | 615.37 |
| Altri autori (Persone) |
PathakYashwant
BenitaSimon <1947-> |
| Soggetto topico |
Antibody-drug conjugates
Drug delivery systems |
| ISBN |
9786613619662
9781280589836 1280589833 9781118228890 1118228898 9781118229019 1118229010 9781118228845 1118228847 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Antibody mediated drug delivery systems : a general review and applications / Navdeep Kaur, Karthikeyan Subramani, and Y.V. Pathak -- Immunoliposomes for cardiovascular targeting / Tatyana Levchenko, William Hartner, and Vladimir P. Torchilin -- Antibody mediated drug delivery systems for breast cancer therapeutics / Leonor Munoz Alcivar and Y.V. Pathak -- Development of immunonconjugates for in vivo delivery : cancer diagnosis, imaging, and therapy / Arut Selvan -- Mathematical models of anti-TNF therapies and their correlation with tuberculosis / Simeone Marino ... [et al.] -- Targeted nanoparticles in radiotherapy / Misty Muscarella and Y.V. Pathak -- Electrically-enhanced delivery of drugs and conjugates for cancer treatment / Arut Selvan, Luca Campana, and Raji Sundararajan -- Characterization of mAb variants and glycosylation / Ting Zheng ... [et al.] -- Antibody mediated drug delivery system for lymphatic targeting treatment / Fang Wu, Hong Ding, and Zhirong Zhang -- Methods for nanoparticle conjugation to monoclonal antibodies (mAbs) / Junling Li and Chin K. Ng -- Single use systems in animal cell-based bioproduction / William G. Whitford -- Immunoliposomes for specific drug delivery / Manuela Calin -- Gene therapy targeting kidney diseases : routes & vehicles / Yoshitaka Isaka, Yoshitsugu Takabatake, and Hiromi Rakugi -- Detection of antibodies to polyethylene glycol polymers using a double antigen bridging immunogenicity ELISA / Yijuan Liu ... [et al.] -- Antibodies in nanomedicine and microimaging methods / Rakesh Sharma -- Methods for polymeric nanoparticle conjugation to mAb / Uyen Minh Le, Hieu Tran, and Y.V. Pathak -- Plant-derived antibodies for academic, industrial, and therapeutic application / Slavko Komarnytsk and Nikolai Borisjuk -- Monoclonal antibodies as biopharmaceuticals / Girish J. Kotwal -- Pulmonary targeting of nanoparticles and monoclonal antibodies (mAb) / Weiyuan Chang -- Antibody mediated arthritis and new therapeutic avenues / Kutty Selva Nandakumar -- Immuno-nanoparticles for nuclear imaging and radiotherapy / Oren Giladi and Simon Benita -- Monoclonal antibodies in the treatment of asthma / Glenn J. Whelan. |
| Record Nr. | UNINA-9910809538703321 |
| Hoboken, N.J., : Wiley, c2012 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiviral drugs / John S. Driscoll
| Antiviral drugs / John S. Driscoll |
| Autore | DRISCOLL, J.S. |
| Pubbl/distr/stampa | Burlington : Ashgate, copyr. 2002 |
| Descrizione fisica | XXV, 174 p. ; 25 cm |
| Disciplina | 615.37 |
| Soggetto topico |
Chemioterapici antivirali
Malattie da virus - Terapia |
| ISBN | 0-566-08310-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-990001132150203316 |
DRISCOLL, J.S.
|
||
| Burlington : Ashgate, copyr. 2002 | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Bacterial vaccines and local immunity : proceedings of Sclavo international conference : Siena, Italy, 17-19 November, 1986 / [a cura di] Aldo Tagliabue, Rino Rappuoli, Sergio E. Piazzi
| Bacterial vaccines and local immunity : proceedings of Sclavo international conference : Siena, Italy, 17-19 November, 1986 / [a cura di] Aldo Tagliabue, Rino Rappuoli, Sergio E. Piazzi |
| Pubbl/distr/stampa | Siena : Sclavo, 1986 |
| Descrizione fisica | 428 p. : ill. ; 24 cm |
| Disciplina | 615.37 |
| Collana | Annali Sclavo |
| Soggetto non controllato |
Vaccinazioni
Immunità |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ita |
| Record Nr. | UNINA-990008851910403321 |
| Siena : Sclavo, 1986 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Basic and Clinical Aspects of Interferon Gamma / / edited by Hridayesh Prakash
| Basic and Clinical Aspects of Interferon Gamma / / edited by Hridayesh Prakash |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
| Descrizione fisica | 1 online resource (130 pages) |
| Disciplina | 615.37 |
| Soggetto topico | Interferon - Therapeutic use |
| ISBN | 1-80355-886-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Perspective Chapter: Macrophages Plasticity and Immune Metabolism -- 2. Interferons Horizon Therapeutics -- 3. Perspective Chapter: Impact of Interferon Alpha/Beta in the Management of Chronic Myeloproliferative Disorders -- 4. Perspective Chapter: Interferon-Gamma in Natural Defence and Prevention of Leprosy -- 5. Perspective Chapter: The Role of Interferon Gamma in Clinical Medicine -- 6. Interferon and HPA Axis: Impact on Neuroimmunological Perturbations. |
| Record Nr. | UNINA-9910633968003321 |
| London : , : IntechOpen, , 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Basic and Clinical Aspects of Interferon Gamma / / edited by Hridayesh Prakash
| Basic and Clinical Aspects of Interferon Gamma / / edited by Hridayesh Prakash |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
| Descrizione fisica | 1 online resource (ix, 130 pages) : illustrations |
| Disciplina | 615.37 |
| Soggetto topico |
Interferon - Therapeutic use
Interleukin-18 Immunology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Perspective Chapter: Macrophages Plasticity and Immune Metabolism -- 2. Interferons Horizon Therapeutics -- 3. Perspective Chapter: Impact of Interferon Alpha/Beta in the Management of Chronic Myeloproliferative Disorders -- 4. Perspective Chapter: Interferon-Gamma in Natural Defence and Prevention of Leprosy -- 5. Perspective Chapter: The Role of Interferon Gamma in Clinical Medicine -- 6. Interferon and HPA Axis: Impact on Neuroimmunological Perturbations. |
| Record Nr. | UNINA-9910687993303321 |
| London : , : IntechOpen, , 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biotherapy
| Biotherapy |
| Pubbl/distr/stampa | [Dordrecht], : Kluwer Academic Publishers |
| Disciplina | 615.37 |
| Soggetto topico |
Biological products - Therapeutic use
Biological response modifiers Immunotherapy Biological Factors - therapeutic use Biothérapie Immunomodulateurs Immunothérapie |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| ISSN | 1573-8280 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996207843003316 |
| [Dordrecht], : Kluwer Academic Publishers | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Breast Cancer Immunotherapy / / edited by Marcus Schmidt, Rita Nanda
| Breast Cancer Immunotherapy / / edited by Marcus Schmidt, Rita Nanda |
| Autore | Schmidt Marcus |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (374 pages) |
| Disciplina |
615.37
571.96 |
| Altri autori (Persone) | NandaRita |
| Collana | Cancer Immunotherapy |
| Soggetto topico |
Immunotherapy
Internal medicine Immunology Gynecology Internal Medicine |
| ISBN | 3-032-06908-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: Immunity and Cancer -- The Functional Cancer Immunity Cycle -- Rationale for Immunotherapy for Breast Cancer -- Tumor-Infiltrating Lymphocytes as a Prognostic and Predictive Marker in Breast Cancer -- Part II: Therapeutic Interventions for Breast Cancer -- Therapeutic Interventions for Breast Cancer: Advanced Breast Cancer -- Immunotherapy in Early Triple-Negative Breast Cancer -- Part III: Vaccines -- Peptide Vaccines in Breast Cancer -- mRNA Vaccination for Breast Cancer -- Part IV: Emerging Therapeutic Strategies -- Radiation and Immunotherapy in Breast Cancer -- The Clinical Development of Immune Checkpoint Inhibitors in Combination with Targeted Therapy in Breast Cancer -- Targeting the STING Pathway in Breast Cancer -- Immunotherapy Combinations and Dual Checkpoint Blockade -- CAR T Cell Strategies for Metastatic Breast Cancer -- Part V: Emerging Biomarkers of Response to Immunotherapy -- Tumor Characteristics -- Host Characteristics in Breast Cancer. |
| Record Nr. | UNINA-9911031666003321 |
Schmidt Marcus
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Convalescent Plasma and Other Antibody Therapies for Infectious Diseases : Lessons learned from COVID-19 and Future Prospects / / edited by Nigel Paneth, Michael J. Joyner, Arturo Casadevall
| Convalescent Plasma and Other Antibody Therapies for Infectious Diseases : Lessons learned from COVID-19 and Future Prospects / / edited by Nigel Paneth, Michael J. Joyner, Arturo Casadevall |
| Autore | Paneth Nigel |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (375 pages) |
| Disciplina | 615.37 |
| Altri autori (Persone) |
JoynerMichael J
CasadevallArturo |
| Collana | Current Topics in Microbiology and Immunology |
| Soggetto topico |
Immunology
Medical microbiology Pharmacology Virology Applied Immunology Medical Microbiology |
| ISBN | 3-031-87167-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | THE LOGIC AND HISTORY OF PASSIVE IMMUNITY AND ANTIBODY THERAPIES -- A BRIEF HISTORY OF POLYCLONAL ANTIBODY THERAPIES AGAINST BACTERIAL AND VIRAL DISEASES BEFORE COVID-19 -- THE IMPORTANCE OF ANTIBODY TITER DETERMINATION TO THE EFFECTIVE USE OF CONVALESCENT PLASMA -- CONVALESCENT PLASMA AND THE US EXPANDED ACCESS PROGRAM: A PERSONAL NARRATIVE -- The safety profile of COVID-19 convalescent plasma -- The Importance of Geographic Proximity of Convalescent Plasma Donors -- Evidence for the efficacy of COVID-19 convalescent plasma -- CONVALESCENT PLASMA FOR IMMUNOCOMPROMISED PATIENTS -- MONOCLONAL ANTIBODY THERAPIES AGAINST SARS-CoV-2: PROMISES AND REALITIES -- Hyperimmune Globulins in COVID-19 -- THE ROLE OF THE PATIENT ADVOCATE DURING A PANDEMIC: THE CASE OF CONVALESCENT PLASMA -- BLOOD BANKING CAPACITY IN LOW-AND MIDDLE-INCOME COUNTRIES: COVID-19 CONVALESCENT PLASMA IN CONTEXT -- HEMOCLEAR: A PRACTICAL AND COST-EFFECTIVE ALTERNATIVE TO CONVENTIONAL CONVALESCENT PLASMA RETRIEVAL METHODS -- GENERATING THE EVIDENCE BASE FOR CONVALESCENT PLASMA USE FOR A NEW INFECTIOUS DISEASE -- CONVALESCENT PLASMA AND OTHER ANTIBODY THERAPIES FOR INFECTIOUS DISEASES – LESSONS LEARNED FROM COVID-19 AND FUTURE PROSPECTS -- MONOCLONAL ANTIBODIES AND HYPERIMMUNE IMMUNOGLOBULINS IN THE NEXT PANDEMIC -- USING PASSIVE ANTIBODY THERAPIES IN THE NEXT PANDEMIC. |
| Record Nr. | UNINA-9911034952703321 |
Paneth Nigel
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||